Skip to main content
SpringerLink
Log in

Ethical Considerations

  • Chapter
Clinical Trials in Rheumatoid Arthritis and Osteoarthritis

Part of the book series: Clinical Trials ((CLINICAL))

  • 1224 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Recommendations guiding medical doctors in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964, and revised by the 52nd World Medical Assembly, Edinburgh, 2000. Available at http://www.wma.net/e/policy/b3.htm.

    Google Scholar 

  2. International Conference on Harmonization. Guidelines for good clinical practice. Federal Register 1997;62:25691–25709. Available at http://www.fda.gov/cder/guidance/959fnl.pdf.

    Google Scholar 

  3. The Committee for Proprietary Medicinal Products. Step 5 note for guidance on good clinical practice (CPMP adopted July 96): CPMP/ICH/135/95. available at http://www.emea.eu.int/pdfs/human/ich/013595en.pdf.

    Google Scholar 

  4. European Parliament. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001. Approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Available at http://eudract.emea.eu.int/docs/Dir2001-20_en.pdf.

    Google Scholar 

  5. DuVal G. Institutional ethics review of clinical study agreements. J Med Ethics 2004;30(1): 30–34.

    Article  PubMed  CAS  Google Scholar 

  6. Weijer C, Freedman B, Fuks A, Robbins J, Shapiro S, Skrutkowska M. What difference does it make to be treated in a clinical trial? A pilot study. Clin Invest Med 1996;19(3):179–183.

    PubMed  CAS  Google Scholar 

  7. Garcia-Porrua C, Gonzalez-Gay MA. Ethical aspects of new medicines targeted at treatment of RA. Ann Rheum Dis 2001;60(3):304.

    Article  PubMed  CAS  Google Scholar 

  8. Kreutz G. European regulatory aspects on new medicines targeted at treatment of rheumatoid arthritis. Ann Rheum Dis 1999;58(Suppl 1):I92–95.

    PubMed  Google Scholar 

  9. Britton A, McKee M, Black N, et al. Choosing between randomised and non-randomised studies: a systematic review. Health Techol Assessment 1998;2(13).

    Google Scholar 

  10. Brevin CR, Bradley C. Patient preferences and randomised clinical trials. BMJ 1989;299:313–315.

    Article  Google Scholar 

  11. Cooper RG, Grant AM, Garratt AM. The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding. Br J Obstetr Gynaecol 1997;104:1367–1373.

    CAS  Google Scholar 

  12. International Commission on Radiation Protection. Recommendations of the International Commission on Radiation Protection. ICRP Publication 60. Ann ICRP 1991;21:1–77.

    Google Scholar 

  13. Watson SJ, Jones AL, Oatway WB, Hughes JS. Ionizing radiation exposure of the UK population UK Review.HPA-RPD-001. Available at: www.hpa.org.uk/radiation/publications/hpa/hpa_hpa_reports/2005/hpa_rpd_001.htm.

    Google Scholar 

  14. Huda W, Gkanatsios NA. Radiation dosimetry for extremity radiographs. Health Phys 1998;75(5):492–499.

    Article  PubMed  CAS  Google Scholar 

  15. European Commission. Radiation Protection 99. Guidance on medical exposures in medical and biomedical research. Luxembourg: Office for Official Publication of the European Communities; 1998.

    Google Scholar 

  16. Aho K, Heliovaara M. Risk factors for rheumatoid arthritis. Ann Med 2004;36(4):242–251.

    Article  PubMed  CAS  Google Scholar 

  17. Klareskog L, Alfredsson L, Rantapaa-Dahlqvist S, Berglin E, Stolt P, Padyukov L. What precedes development of rheumatoid arthritis? Ann Rheum Dis 2004;63(Suppl 2):ii28–ii31.

    Article  PubMed  Google Scholar 

  18. Barton A, John S. Approaches to identifying genetic predictors of clinical outcome in rheumatoid arthritis. Am J Pharmacogenomics 2003;3(3):181–191.

    Article  PubMed  CAS  Google Scholar 

  19. Human tissue and biological samples for use in research - operational and ethical guidelines 2001. at Available at http://www.mrc.ac.uk/pdf-tissue_guide_fin.pdf.

    Google Scholar 

  20. Evans CH, Gouze JN, Gouze E, Robbins PD, Ghivizzani SC. Osteoarthritis gene therapy. Gene Ther. 2004;11(4):379–389.

    Article  PubMed  CAS  Google Scholar 

  21. Trippel SB, Ghivizzani SC, Nixon AJ. Gene-based approaches for the repair of articular cartilage. Gene Ther 2004;11(4):351–359.

    Article  PubMed  CAS  Google Scholar 

  22. Jorgensen C, Gordeladze J, Noel D. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 2004;15(5):406–410.

    Article  PubMed  CAS  Google Scholar 

  23. U.S. Department of Health and Human Services. Protection of human subjects. Belmont Report: notice of report for public comment. Federal Register 1979;44:23191–23197. Available at http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm.

    Google Scholar 

  24. 21 Code of Federal Regulations 50.20. General requirements for informed consent. Available at http://www.fda.gov/oc/ohrt/irbs/.

    Google Scholar 

  25. Kent G. The views of members of local research ethics committees, researchers and members of the public towards the roles and functions of LRECs. J Med Ethics 1997;23:186–190.

    PubMed  CAS  Google Scholar 

  26. Grainge MJ, Coupland CA, Cliffe SJ, Chilvers CE, Hosking DJ. Cigarette smoking, alcohol and caffeine consumption, and bone mineral density in postmenopausal women. The Nottingham EPIC Study Group. Osteoporos Int 1998;8:355–363.

    CAS  Google Scholar 

  27. Jadad A. Randomised controlled trials. London: BMJ Books; 1998.

    Google Scholar 

  28. Fries JF, Krishnan E. Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development. Arthritis Res Ther 2004;6(3):R250–255.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Director, Medical Physics, City Hospital, Nottingham, UK

    Derek Pearson

Authors
  1. Derek Pearson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Colin G. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK

    David M. Reid MBChB, MD, FRCP

  2. Bio-Imaging Technologies Inc, Newtown, PA, USA

    Colin G. Miller BSc, PhD, FICR

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Pearson, D., Miller, C.G. (2008). Ethical Considerations. In: Reid, D.M., Miller, C.G. (eds) Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. Clinical Trials. Springer, London. https://doi.org/10.1007/978-1-84628-742-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-742-8_7

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-874-9

  • Online ISBN: 978-1-84628-742-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation